ACHE and early-onset autosomal dominant Alzheimer disease: Acetylcholinesterase inhibitors (AChEI) are indicated in M-NCD due to Alzheimer’s disease, Lewy body disease and Parkinson’s disease, and memantine is indicated in M-NCD due to Alzheimer’s disease.